Aberrant Histone Methylation in Patients with Graves' Disease.

Ni YanKaida MuXiao-Fei AnLing LiQiu QinRong-Hua Song Qiu-Ming YaoXiao-Qing ShaoJin-An Zhang

Published in: International journal of endocrinology (2019)

These findings firstly suggested that the histone methylation was aberrant in PBMCs of GD patients, which could be possibly attributed to the deregulation of epigenetic modifier genes. Abnormal histone methylation modification may be involved in the pathogenesis of GD.

Keyphrases

dna methylation
genome wide
end stage renal disease
gene expression
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
bioinformatics analysis